JP7270141B2 - シアル酸結合性ポリペプチド - Google Patents

シアル酸結合性ポリペプチド Download PDF

Info

Publication number
JP7270141B2
JP7270141B2 JP2019557612A JP2019557612A JP7270141B2 JP 7270141 B2 JP7270141 B2 JP 7270141B2 JP 2019557612 A JP2019557612 A JP 2019557612A JP 2019557612 A JP2019557612 A JP 2019557612A JP 7270141 B2 JP7270141 B2 JP 7270141B2
Authority
JP
Japan
Prior art keywords
sialic acid
sia
nanb
conjugate
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019557612A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020517280A (ja
JP2020517280A5 (https=
Inventor
ロレッタ ヤン，
カウサー エヌ． サムリ，
ロバート ジェイ． ウッズ，
シェンチェン ウー，
ジョン シー． クーパー，
マロリー ケー． ポール，
マシュー ジェイ． サンダース，
ジアド エム． エルター，
Original Assignee
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド
グリコセンサーズ アンド ダイアグノスティクス リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド, グリコセンサーズ アンド ダイアグノスティクス リミテッド ライアビリティ カンパニー filed Critical ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド
Publication of JP2020517280A publication Critical patent/JP2020517280A/ja
Publication of JP2020517280A5 publication Critical patent/JP2020517280A5/ja
Priority to JP2023026222A priority Critical patent/JP2023057175A/ja
Application granted granted Critical
Publication of JP7270141B2 publication Critical patent/JP7270141B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2019557612A 2017-04-24 2018-04-24 シアル酸結合性ポリペプチド Active JP7270141B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023026222A JP2023057175A (ja) 2017-04-24 2023-02-22 シアル酸結合性ポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762489243P 2017-04-24 2017-04-24
US62/489,243 2017-04-24
PCT/US2018/029079 WO2018200478A2 (en) 2017-04-24 2018-04-24 Sialic acid binding polypeptide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023026222A Division JP2023057175A (ja) 2017-04-24 2023-02-22 シアル酸結合性ポリペプチド

Publications (3)

Publication Number Publication Date
JP2020517280A JP2020517280A (ja) 2020-06-18
JP2020517280A5 JP2020517280A5 (https=) 2021-06-10
JP7270141B2 true JP7270141B2 (ja) 2023-05-10

Family

ID=63919217

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019557612A Active JP7270141B2 (ja) 2017-04-24 2018-04-24 シアル酸結合性ポリペプチド
JP2023026222A Withdrawn JP2023057175A (ja) 2017-04-24 2023-02-22 シアル酸結合性ポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023026222A Withdrawn JP2023057175A (ja) 2017-04-24 2023-02-22 シアル酸結合性ポリペプチド

Country Status (5)

Country Link
US (1) US11434479B2 (https=)
EP (1) EP3615670A4 (https=)
JP (2) JP7270141B2 (https=)
AU (1) AU2018258251B2 (https=)
WO (1) WO2018200478A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018258251B2 (en) 2017-04-24 2024-06-20 Glycosensors And Diagnostics, Llc Sialic acid binding polypeptide
EP4601657A1 (en) * 2022-10-14 2025-08-20 The Children's Medical Center Corporation Multiple antigen presenting system (maps) cross-linked using a bifunctional fusion protein and its use in vaccines
CN115876993B (zh) * 2022-11-17 2024-10-15 沈阳农业大学 基于生物膜干涉技术检测病原生物凝集素与唾液酸乳糖亲和力方法的建立
WO2025080776A2 (en) * 2023-10-13 2025-04-17 The Children's Medical Center Corporation Vaccine compositions comprising sialic acid binding domain (sbd) proteins and use thereof to enhance immune response

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005069A1 (en) 2011-03-01 2014-01-02 Glycosensors And Diagnostics, Llc. Glycoprofiling with multiplexed suspension arrays
WO2015161201A1 (en) 2014-04-18 2015-10-22 University Of Georgia Research Foundation, Inc. Carbohydrate-binding protein
JP2016000044A (ja) 2008-12-10 2016-01-07 ユニバーシティ オブ ジョージア リサーチ ファウンデーション インコーポレイテッド グリカン特異的分析ツール

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352607A (en) 1987-05-22 1994-10-04 Louisiana State University And Agricultural College Molecular clone of a chitinase gene from vibrio parahemolyticus
US5587292A (en) 1987-05-22 1996-12-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnosis of fungal infections with a chitinase
US5935804A (en) 1997-03-21 1999-08-10 Laine; Roger A. Method for detecting eubacteria in biological samples with catalytically inactive murein binding enzymes
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
TW496775B (en) 1999-03-15 2002-08-01 Aviva Bioscience Corp Individually addressable micro-electromagnetic unit array chips
IL129835A (en) 1999-05-06 2008-03-20 Ofer Markman Polysaccharide sequencing and structure determination
US6376210B1 (en) 1999-07-06 2002-04-23 General Atomics Methods and compositions for assaying analytes
US6780627B1 (en) 2000-01-31 2004-08-24 Millennium Pharmaceuticals, Inc. 22438, 23553, 25278, and 26212 novel human sulfatases
US20060141480A1 (en) 1999-11-10 2006-06-29 Kalyanaraman Ramnarayan Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics and clinical applications
JP2005510229A (ja) 2001-11-28 2005-04-21 ネオーズ テクノロジーズ， インコーポレイテッド アミダーゼを用いる糖タンパク質のリモデリング
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
US7132257B2 (en) 2003-07-10 2006-11-07 E. I. Du Pont De Nemours And Company Production or aromatic carotenoids in gram negative bacteria
AU2004299992B2 (en) 2003-12-18 2011-03-24 Procognia Ltd. Method for analyzing a glycomolecule
US20060040327A1 (en) 2004-08-18 2006-02-23 Terry Amiss Methods of screening proteins
US20060121042A1 (en) 2004-10-27 2006-06-08 Medimmune, Inc. Modulation of antibody specificity by tailoring the affinity to cognate antigens
US20060172339A1 (en) 2004-11-29 2006-08-03 Perkinelmer Las, Inc. Particle-based multiplex assay for identifying glycosylation
EP2444499A3 (en) 2006-05-02 2012-05-09 Allozyne, Inc. Amino acid substituted molecules
US9201010B2 (en) 2008-05-01 2015-12-01 The United States Of America, As Represented By The Secretary Of The Navy Fluorescent organic nanoparticles
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US20180259508A1 (en) 2008-12-10 2018-09-13 University Of Georgia Research Foundation, Inc. Glycan-specific analytical tools
US20110257032A1 (en) 2010-04-16 2011-10-20 Massachusetts Institute Of Technology Modular glycan arrays
CA2839932C (en) 2011-06-07 2022-07-05 Ibio, Inc. In vivo de-glycosylation of recombinant proteins by co-expression with pngase f
WO2016003795A1 (en) 2014-07-02 2016-01-07 New England Biolabs, Inc. Universal n-glycan binding reagent
AU2018258251B2 (en) 2017-04-24 2024-06-20 Glycosensors And Diagnostics, Llc Sialic acid binding polypeptide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016000044A (ja) 2008-12-10 2016-01-07 ユニバーシティ オブ ジョージア リサーチ ファウンデーション インコーポレイテッド グリカン特異的分析ツール
US20140005069A1 (en) 2011-03-01 2014-01-02 Glycosensors And Diagnostics, Llc. Glycoprofiling with multiplexed suspension arrays
WO2015161201A1 (en) 2014-04-18 2015-10-22 University Of Georgia Research Foundation, Inc. Carbohydrate-binding protein

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FEBS Letters (2008) Vol.582, pp.3348-3352
Glycoconjugate Journal (2009) Vol.26, pp.827-828, Abstract Number 78
J. Mol. Biol. (2008) Vol.384, pp.436-449

Also Published As

Publication number Publication date
JP2023057175A (ja) 2023-04-20
US20210009975A1 (en) 2021-01-14
JP2020517280A (ja) 2020-06-18
AU2018258251A1 (en) 2019-11-07
AU2018258251B2 (en) 2024-06-20
EP3615670A4 (en) 2021-01-27
US11434479B2 (en) 2022-09-06
EP3615670A2 (en) 2020-03-04
WO2018200478A3 (en) 2018-11-29
CA3061176A1 (en) 2018-11-01
WO2018200478A2 (en) 2018-11-01

Similar Documents

Publication Publication Date Title
JP2023057175A (ja) シアル酸結合性ポリペプチド
Alley Jr et al. High-sensitivity analytical approaches for the structural characterization of glycoproteins
Zhang et al. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry
Wong Protein glycosylation: new challenges and opportunities
Li et al. Proteoglycan sequence
Harvey Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2007–2008
JP6083649B2 (ja) 未分化細胞検出方法及び複合糖質検出方法
Qin et al. Proteomics analysis of O-GalNAc glycosylation in human serum by an integrated strategy
Díaz-Fernández et al. Post-translational modifications in tumor biomarkers: the next challenge for aptamers?
Patwa et al. Glycoprotein analysis using protein microarrays and mass spectrometry
US11001824B1 (en) Carbohydrate-binding protein
Gonzalez-Begne et al. Characterization of the human submandibular/sublingual saliva glycoproteome using lectin affinity chromatography coupled to multidimensional protein identification technology
US20090053828A1 (en) Detection of glycopeptides and glycoproteins for medical diagnostics
Yang et al. Online proteolysis and glycopeptide enrichment with thermoresponsive porous polymer membrane reactors for nanoflow liquid chromatography-tandem mass spectrometry
Goso et al. Comparison of methods to release mucin-type O-glycans for glycomic analysis
Yang et al. Solid‐phase glycan isolation for glycomics analysis
Yamada et al. Analysis of O-glycans as 9-fluorenylmethyl derivatives and its application to the studies on glycan array
Vainauskas et al. Profiling of core fucosylated N-glycans using a novel bacterial lectin that specifically recognizes α1, 6 fucosylated chitobiose
Maliepaard et al. Glycoproteomics-compatible MS/MS-based quantification of glycopeptide isomers
Voronina et al. Probing blood plasma protein glycosylation with infrared spectroscopy
Kim et al. Peptide-N-glycosidase F or A treatment and procainamide-labeling for identification and quantification of N-glycans in two types of mammalian glycoproteins using UPLC and LC-MS/MS
Zhang et al. Analysis of O-acetylated sialic acids in dried blood spots
Flowers et al. Deciphering isomers with a multiple reaction monitoring method for the complete detectable O-glycan repertoire of the candidate therapeutic, lubricin
CA3061176C (en) Sialic acid binding polypeptide
US20240109945A1 (en) Reagents for detection of n-glycosylation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210423

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210423

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220520

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220720

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230222

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230222

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230301

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20230302

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230405

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230410

R150 Certificate of patent or registration of utility model

Ref document number: 7270141

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150